In a transgenic zebrafish melanoma model, the mitf promoter-driven BRAFV600E [15] and N-RASQ61K [19] genes induced tumors only on a p53-deficient background, whereas H-RASG12V was capable of tumor formation without p53 deficiency [20]. This evidence concerns the gene MITF and neoplasm.